ERBB2 and neoplasm: Kallergi G et al [11] showed that expression of VEGFR-2 on circulating tumor cells occurred in 70% of circulating tumor cells, but the expression of this receptor did not correlate with the ER/PR or HER-2/neu status of the primary tumor, and these results are consistent with our results.